Long-Term Results and Risk Factors of Treatment for Post-Infarction Ventricular Septal Rupture: A Single-Center Experience
DOI:
https://doi.org/10.59958/hsf.5665Keywords:
myocardial infarction, surgery, ventricular septal rupture, risk factor, mortalityAbstract
Background: Ventricular septal rupture (VSR) following myocardial infarction (MI) is a rare but lethal complication. We analyzed the long-term results and risk factors for survival in the treatment of VSR. Methods: From January 2012 to December 2021, 115 consecutive patients with post-MI VSR were admitted to our hospital. Depending on different treatment methods patients were divided into following three groups: medical, transcatheter intervention, and surgical repair. During the study, relevant clinical data, operation-related conditions, and follow-up data were analyzed. The Kaplan–Meier method and log-rank test were used to determine the cumulative incidence of mortality. The independent risk factors for patient mortality were evaluated by multivariate logistic regression. Results: The mean follow-up time was 43.4 ± 34.7 months. The overall in-hospital, 30-day, and long-term mortality rates were 24.3%, 38.3%, and 51.3%, respectively. In the medical group, the in-hospital and 30-day mortality rates were 46.7 % (21/45) and 82.2 % (37/45), respectively, with only three patients alive at follow-up. In the transcatheter intervention group, 30-day and long-term mortality rates were 12% and 28%, respectively. In the surgical repair group, 30-day and long-term mortality rates were 8.9% and 22.2%, respectively. Compared with the surgery-group patients, patients with transcatheter intervention had a longer time from VSR to intervention. Logistic regression analysis revealed that age, previous infarction, Killip class, serum creatinine, Troponin T, N-terminal pro-B-type natriuretic peptide, and medical strategy were risk factors for all-cause mortality. Conclusions: The 30-day and long-term outcomes of patients treated with surgical repair and transcatheter intervention were significantly better than medically treated patients.
References
Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB, et al. Trends in Incidence and Mortality Rates of Ventricular Septal Rupture during Acute Myocardial Infarction. The American Journal of Cardiology. 2010; 106: 1095–1100.
Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000;101: 27–32.
Ma D, Zhang Z, Zhang S, Wang Z, Zhang G, Wang C, et al. Treatment Strategies for Ventricular Septal Rupture After Myocardial Infarction: A Single-Center Experience. Frontiers in Cardiovascular Medicine. 2022; 9: 843625.
Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. European Heart Journal. 2009; 30: 81–88.
Arnaoutakis GJ, Zhao Y, George TJ, Sciortino CM, McCarthy PM, Conte JV. Surgical Repair of Ventricular Septal Defect after Myocardial Infarction: Outcomes from the Society of Thoracic Surgeons National Database. The Annals of Thoracic Surgery. 2012; 94: 436–444.
Ronco D, Matteucci M, Kowalewski M, De Bonis M, Formica F, Jiritano F, et al. Surgical Treatment of Postinfarction Ventricular Septal Rupture. JAMA Network Open. 2021; 4: e2128309.
Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. European Heart Journal. 2014; 35: 2060–2068.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018; 39: 119–177.
Zhu XY, Qin YW, Han YL, Zhang DZ, Wang P, Liu YF, et al. Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study. EuroIntervention. 2013; 8: 1270–1276.
Zhao K, Li B, Sun B, Tao D, Jiang H, Wang H. Survival and risk factors associated with surgical repair of ventricular septal rupture after acute myocardial infarction: A single-center experience. Frontiers in Cardiovascular Medicine. 2022; 9: 933103.
Matteucci M, Ronco D, Corazzari C, Fina D, Jiritano F, Meani P, et al. Surgical Repair of Postinfarction Ventricular Septal Rupture: Systematic Review and Meta-Analysis. The Annals of Thoracic Surgery. 2021; 112: 326–337.
Daggett WM, Guyton RA, Mundth ED, Buckley MJ, McEnany MT, Gold HK, et al. Surgery for Post-Myocardial Infarct Ventricular Septal Defect. Annals of Surgery. 1977; 186: 260–271.
Calvert PA, Cockburn J, Wynne D, Ludman P, Rana BS, Northridge D, et al. Percutaneous Closure of Postinfarction Ventricular Septal Defect: in-hospital outcomes and long-term follow-up of UK experience. Circulation. 2014; 129: 2395–2402.
Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H. Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence. EuroIntervention. 2016; 12: 94–102.
Kariyanna PT, Tadayoni A, Jayarangaiah A, Hegde S, Jayaranagaiah A, McFarlane IM. Percutaneous Closure of Post-infarction and Iatrogenic Ventricular Septal Ruptures Using Amplatzer Occluder(R): A Systematic Review. American Journal of Medical Case Reports. 2021; 9: 184–189.
Takahashi H, Arif R, Almashhoor A, Ruhparwar A, Karck M, Kallenbach K. Long-term results after surgical treatment of postinfarction ventricular septal rupture. European Journal of Cardio-Thoracic Surgery. 2015; 47: 720–724.
Barrabés JA, Buera I, Rodríguez-Lecoq R. Can we improve the prognosis of postinfarction ventricular septal rupture? Revista Espanola de Cardiologia. 2021; 74: 737–739. (In English, Spanish)
Giblett JP, Jenkins DP, Calvert PA. Transcatheter treatment of postinfarct ventricular septal defects. Heart. 2020; 106: 878–884.
O'Donoghue ML, Morrow DA, Cannon CP, Jarolim P, Desai NR, Sherwood MW, et al. Multimarker Risk Stratification in Patients with Acute Myocardial Infarction. Journal of the American Heart Association. 2016; 5: e002586.
Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Nagashima M, Fujii S, et al. Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry. Circulation Journal. 2007; 71: 1354–1359.
